Nomic Bio

Total raised$42.0M
StageSeries B
Hiring pace6 roles / 90d
Founded2017
Team size51-200 employees
HQMontreal, QC
IndustriesBiotechnologyProteomicsLife SciencesDiagnostics

About Nomic Bio

Nomic develops a high-throughput proteomics platform to profile proteins at large scale. Its mission is to make biology easier to measure. Spun out of McGill University, Nomic is headquartered in Montreal, Canada, with a satellite research lab in Boston, Massachusetts, and the majority of its team based in Montreal. The company has partnered with dozens of drug discovery groups, including GSK and four of the top 10 pharmaceutical companies. It recently launched a manufacturing and protein profiling facility capable of multiplexed measurement of more than 2.5 million samples per year, generating the equivalent of 500 million protein assays.

Open positions · 6

Location

Culture & values

The majority of Nomic's team is based in Montreal and works in a new shared office/laboratory space with an in-person, but flexible work-from-home policy.

Nomic describes itself as building a diverse team of engineers, scientists, and world-changers.

The company values cross-disciplinary collaboration among engineers, scientists, and highly-skilled lab operators.

Nomic embraces a first principles approach to solving difficult problems.

The organization aims to grow quickly to meet customer demand while continuing to develop its core technology.

Life at Nomic Bio

Frequently asked questions

Companies similar to Nomic Bio

EVANIUM

EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.

Biotechnology1-10
9 Mothers

9 Mothers Defense develops fast and cost-effective counter-small UAS (C-sUAS). The company uses AI for detection, tracking and defensive systems to protect against aerial threats, building AI-powered machines designed to intercept and neutralize Group 1/sUAS threats in real time. Operating in the defense industry with a focus on immediate threat countermeasures, it pursues mission-critical work countering immediate real-world aerial threats. Meaningful early equity for foundational owners and direct roadmap influence give employees a seat at the table shaping product and technology trajectory from day one, with zero red tape allowing them to make technical decisions autonomously. An on-site team in Austin, Texas builds robots, sensors and models to control them from scratch, using Python and Rust on embedded hardware, and their work spans vision, acoustics, radar and control systems across hardware and software.

Aerospace and Defense
Aira

Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.

HealthTech1-10